You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

conditionally replicative adenovirus

Showing 1 - 25 of 339
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer, Brain Tumor, Glioma Trial in Canada, United States (DNX-2401, pembrolizumab)

Completed
  • Brain Cancer
  • +10 more
  • DNX-2401
  • pembrolizumab
  • Little Rock, Arkansas
  • +14 more
Jul 13, 2021

Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)

Recruiting
  • Head and Neck Cancer
  • +6 more
  • Recombinant L-IFN adenovirus injection
  • Shanghai, Shanghai, China
    Shanghai Fengxian District Central Hospital
Jan 16, 2022

Prostate Cancer Trial in Birmingham (AdNRGM)

Completed
  • Prostate Cancer
  • AdNRGM
  • Birmingham, West Midlands, United Kingdom
    Queen Elizabeth Hospital Birmingham, University Hospitals Birmin
Nov 2, 2021

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Glioblastoma or Gliosarcoma Trial in United States (Single intratumoral injection of DNX-2401, Interferon-gamma)

Completed
  • Glioblastoma or Gliosarcoma
  • Tampa, Florida
  • +3 more
Jul 12, 2018

Melanoma (Skin), Triple-Negative Breast Cancer, NSCLC Trial (PeptiCRAd-1, Cyclophosphamide, Pembrolizumab)

Not yet recruiting
  • Melanoma (Skin)
  • +2 more
  • (no location specified)
Aug 5, 2022

Uveal Melanoma, Metastatic Trial in Hospitalet de Llobregat (AloCelyvir)

Not yet recruiting
  • Uveal Melanoma, Metastatic
  • AloCelyvir
  • Hospitalet de Llobregat, Barcelona, Spain
    ICO Hospitalet
Sep 8, 2021

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Fatty Liver Trial in Boston (GE ultrasound system with increased

Not yet recruiting
  • Nonalcoholic Fatty Liver
  • +2 more
  • GE ultrasound system with increased acoustic output settings
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 19, 2023

Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)

Enrolling by invitation
  • Malignant Melanomas
  • Recombinant Human Adenovirus Type 5 Injection
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023

Bioequivalence Trial in Yaroslavl (Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg)

Recruiting
  • Bioequivalence
  • Clopidogrel film-coated tablet 75 mg
  • Plavix® film-coated tablet 75 mg
  • Yaroslavl, Yaroslavl Region, Russian Federation
    State Autonomous Healthcare Facility of the Yaroslavl Region "Cl
Jun 28, 2023

HIV-1-infection Trial in Kenya, Uganda, Zambia (Vaccine, Placebo)

Active, not recruiting
  • HIV-1-infection
  • Vaccine
  • Placebo
  • Kilifi, Kenya
  • +3 more
Jun 21, 2022

Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

Not yet recruiting
  • Adenovirus
  • +2 more
  • Specific T- Lymphocytes
  • Pittsburgh, Pennsylvania
    UPMC Children's Hospital of Pittsburgh
Sep 8, 2023

Lung Cancer Trial (TILT-123, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • TILT-123
  • Pembrolizumab
  • (no location specified)
Nov 5, 2023

Heart Failure Trial in Dallas (Medically Tailored Meals, Fresh Produce, Control (financial support only))

Not yet recruiting
  • Heart Failure
  • Medically Tailored Meals
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 31, 2023

Bioequivalence Trial in Yaroslavl (Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg)

Recruiting
  • Bioequivalence
  • Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg
  • Yaroslavl, Russian Federation
    State Budgetary Healthcare Institution of the Yaroslavl Region "
Nov 30, 2022

Pathology of Helicases and Premature Aging: Study by Derivation

Terminated
  • Age Problem
  • taking of cutaneous cells
  • Montpellier, France
    University Hospital Montpellier
Dec 8, 2021

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in

Recruiting
  • Malignant Pleural Mesothelioma, Advanced
  • Oncolytic Adenovirus H101
  • Programmed death receptor-1 inhibitor
  • Tianjin, Tianjin, China
    Tianjin Medical Unversity Second Hospital
Sep 2, 2023

Bladder Cancer Trial in Hangzhou (H101, Camrelizumab)

Recruiting
  • Bladder Cancer
  • H101, Camrelizumab
  • Hangzhou, Zhejiang, China
    Hua Wang
Oct 2, 2022

Adenovirus Infection Trial in Columbus (Adenovirus Specific T lymphocytes)

Recruiting
  • Adenovirus Infection
  • Adenovirus Specific T lymphocytes
  • Columbus, Ohio
    Nationwide Children's Hospital
Sep 1, 2022

COVID-19 Trial in Wuhan (Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For

Recruiting
  • COVID-19
  • Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 1, 2023

Adenovirus, Primary Immune Deficiency Disorder Trial in United States (cytotoxic t-lymphocytes)

Recruiting
  • Adenovirus
  • Primary Immune Deficiency Disorder
  • cytotoxic t-lymphocytes
  • Los Angeles, California
  • +8 more
Sep 27, 2022

Systemic Lupus Erythematosus Trial (Telitacicept, Hydroxychloroquine, Prednisone)

Not yet recruiting
  • Systemic Lupus Erythematosus
  • Telitacicept
  • +6 more
  • (no location specified)
Dec 28, 2022

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Untreated Advanced NSCLC Trial in Fuzhou (Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and

Recruiting
  • Untreated Advanced Non-small Cell Lung Cancer
  • Recombinant human adenovirus type 5 injection (H101) combined with tirilizumab and platinum-containing two-drug chemotherapy
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Nov 13, 2023

Locally Advanced or Metastatic Melanoma Trial in L'Hospitalet del Llobregat (ICOVIR-5)

Completed
  • Locally Advanced or Metastatic Melanoma
  • ICOVIR-5
  • L'Hospitalet del Llobregat, Barcelona, Spain
    Institut Català d'Oncologia - L'Hospitalet
Aug 28, 2017